ACA
IBB icon

American Capital Advisory’s iShares Biotechnology ETF IBB Stock Holding History

American Capital Advisory’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-891
Closed -$113K – 1025
2025
Q2 		$113K Hold
891
– – 0.06% 120
2025
Q1 		$114K Hold
891
– – 0.06% 117
2024
Q4 		$118K Hold
891
– – 0.07% 118
2024
Q3 		$130K Hold
891
– – 0.08% 112
2024
Q2 		$121K Hold
891
– – 0.09% 107
2024
Q1 		$115K Hold
891
– – 0.1% 107
2023
Q4 		$121K Buy
+891
New +$109K 0.09% 107

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Capital Advisory's IBB Position: Q3 2025 in Review

American Capital Advisory sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 891 shares — an estimated $113K sold.

American Capital Advisory first reported a position in IBB in Q4 2023 and held it in 7 quarters. The position peaked at $130K in Q3 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • American Capital Advisory reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • American Capital Advisory sold 891 iShares Biotechnology ETF shares in Q3 2025, an estimated $113K.
  • American Capital Advisory first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 7 quarters.
  • American Capital Advisory's iShares Biotechnology ETF position peaked at $130K in Q3 2024.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on American Capital Advisory's 13F filing for Q3 2025, filed 28 Oct 2025.